Home LiteratureArticle Details
PMID: 12241648 Published · ppublish English Comment Journal Article

Ovarian cancer chemotherapy: carboplatin as standard.

Lancet (London, England) ·Vol. 360 ·No. 9332 ·2002-08-17 ·Pages 500-1

Tattersall MN

Abstract

暂无摘要

MeSH Terms
Antineoplastic Combined Chemotherapy Protocols/therapeutic use Carboplatin/therapeutic use Cyclophosphamide/therapeutic use Doxorubicin/therapeutic use Female Humans Ovarian Neoplasms/drug therapy Peptichemio/therapeutic use
Chemicals
Doxorubicin Cyclophosphamide Peptichemio Carboplatin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Tattersall Martin N
Department of Cancer Medicine, University of Sydney, Sydney, NSW 2006, Australia. mtatt@med.usyd.edu.au
Supplementary Concepts
CAP protocol 2 (Protocol)
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/s0140-6736(02)09757-x
Email
mtatt@med.usyd.edu.au
Published
2002-08-17
Pages
500-1
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentOn
PMID: 12241653
External Links
PubMed source DOI: 10.1016/s0140-6736(02)09757-x View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2